Meeting Report

New Treatment Strategies Making an Impact in Multiple Myeloma

Presented by Mollie Moran, CNP, and Jeffrey Jones, MD, MPH

Winship Cancer Institute of Emory University, Atlanta, Georgia

Presenters’ disclosures of potential conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2017;8:285–290 | https://doi.org/10.6004/jadpro.2017.8.3.12 | © 2017 Harborside Press®


  

ABSTRACT

Even though multiple myeloma remains incurable, mean overall survival has improved dramatically as newer game-changing therapies enter the scene. At the same time, treatment decisions and the management of toxicities related to newer drug regimens are becoming more complex.


For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here